Delox is designing and developing a new generation of bio-decontamination devices.
Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design, development, and production of a vast portfolio of automatic biodecontamination robots. Target applications include the sterilization of medical devices in hospitals, health centers and field hospitals (for humanitarian missions, catastrophe situations, and war zones); room biodecontamination in hospitals, pharma, food industry and space; and laboratory equipment biodecontamination.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 18, 2022 | Seed | €750K | 1 | — | — | Detail |
Jul 1, 2018 | Grant | €200K | 1 | — | — | Detail |
Jul 1, 2018 | Seed | €300K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Bionova Capital | — | Seed |
H2020-SME-Instrument program | — | Grant |